✦ LIBER ✦

Epidermal Growth Factor Ameliorates Autosomal Recessive Polycystic Kidney Disease in Mice

✍ Scribed by Vincent H. Gattone II; Dawne A. Lowden; Benjamin D. Cowley Jr.

Book ID: 115597367
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 567 KB
Volume: 169
Category: Article
ISSN: 0012-1606
DOI: 10.1006/dbio.1995.1164

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liver disease in autosomal recessive pol

Liver disease in autosomal recessive polycystic kidney disease

✍ Benjamin L. Shneider; Margret S. Magid 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

An Inborn Error in Epidermal Growth Fact

An Inborn Error in Epidermal Growth Factor Prohormone Metabolism in a Mouse Model of Autosomal Recessive Polycystic Kidney Disease

✍ J. Lakshmanan; D.A. Fisher 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 599 KB

Recombinant human growth hormone therapy

Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease

✍ Lilova, Marusia; Kaplan, Bernard S.; Meyers, Kevin E. C. 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 173 KB

Autosomal recessive polycystic kidney di

Autosomal recessive polycystic kidney disease in 15 Arab children

✍ T. K. Mattoo; Y. Khatani; B. Ashraf 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 294 KB

Functional analysis ofPKHD1splicing in a

Functional analysis ofPKHD1splicing in autosomal recessive polycystic kidney disease

✍ Carsten Bergmann; Valeska Frank; Fabian Küpper; Christa Schmidt; Jan Senderek; K 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 208 KB

PKHD1 mutations in autosomal recessive p

PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD)

✍ Carsten Bergmann; Jan Senderek; Fabian Küpper; Frank Schneider; Christian Dornia 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

## Communicated by Jurgen Horst Autosomal recessive polycystic kidney disease (ARPKD) is an important cause of childhood renal-and liverrelated morbidity and mortality. The clinical spectrum is widely variable. About 30 to 50% of affected individuals die in the neonatal period, while others survive